Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy
Article Sidebar
Main Article Content
Background:
Patients with lupus nephritis could progress to end-stage renal disease (10-22%); hence, kidney transplants should be considered as the treatment of choice for these patients.
Objective:
To evaluate the clinical outcomes after kidney transplants in patients with chronic kidney diseases secondary to lupus nephritis, polycystic kidney disease and diabetes nephropathy at Pablo Tobon Uribe Hospital.
Methods:
A descriptive and retrospective study performed at one kidney transplant center between 2005 and 2013.
Results:
A total of 136 patients, 27 with lupus nephritis (19.9%), 31 with polycystic kidney disease (22.8%) and 78 with diabetes nephropathy (57.4%), were included in the study. The graft survivals after one, three and five years were 96.3%, 82.5% and 82.5% for lupus nephritis; 90%, 86% and 76.5% for polycystic kidney disease and 91.7%, 80.3% and 67.9% for diabetes nephropathy, respectively, with no significant differences (p= 0.488); the rate of lupus nephritis recurrence was 0.94%/person-year. The etiology of lupus vs diabetes vs polycystic disease was not a risk factor for a decreased time of graft survival (Hazard ratio: 1.43; 95% CI: 0.52-3.93).
Conclusion:
Kidney transplant patients with end stage renal disease secondary to lupus nephritis has similar graft and patient survival success rates to patients with other kidney diseases. The complication rate and risk of recurrence for lupus nephritis are low. Kidney transplants should be considered as the treatment of choice for patients with end stage renal disease secondary to lupus nephritis.
.Burgos PI, Perkins EL, Pons-Estel GJ, Kendrick SA, Liu JM, Kendrick WT, et al. Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution. Arthritis Rheum. 2009;60(9):2757–2766
.Bastian H, Roseman J, McGwin Gj, Alarcón G, Friedman A, Fessler B, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002;11(3):152–160
Kang S-H, Chung B-H, Choi S-R, Lee J-Y, Park H-S, Sun I-O, et al. Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med. 2011;26(1):60
Mojcik CF, Klippel JH. End-stage renal disease and systemic lupus erythematosus. Am J Med. 1996;101:100–107
Wu M-J, Lo Y-C, Lan J-L, Yu T-M, Shu K-H, Chen D-Y, et al. Outcome of lupus nephritis after entering into end-stage renal disease and comparison between different treatment modalities: a nationwide population-based cohort study in taiwan. Transplant Proc. 2014;46(2):339–341
Nee R, Jindal RM, Little D, Ramsey-Goldman R, Agodoa L, Hurst FP, et al. Racial differences and income disparities are associated with poor outcomes in kidney transplant recipients with lupus nephritis. Transplantation. 2013;95(12):1471–1478
Collins A, Foley R, Chavers B, Gilbertson D, Herzog C, Johansen K, et al. United States renal data system 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59 suppl 1:A7, e1-420
Anaya JM, Uribe M, Pérez A, Sánchez JF, Pinto LF, Molina JF, et al. Clinical and immunological factors associated with lupus nephritis in patients from northwestern Colombia. Biomédica. 2003;23:293–300
Hellerstedt W, Johnson W, Ascher N, Kjellstrand C, Knutson R, Shapiro F, et al. Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc. 1984;59(1):776–783
Oliveira C, Oliveira I, Bacchiega A, Klum E, Albuquerque E, Souza E, et al. Renal transplantation in lupus nephritis?:: a Brazilian cohort. Lupus. 2012;21:570–574
Ponticelli C, Moroni G. Renal transplantation in lupus nephritis. Lupus. 2005;14(1):95–98
Yu T-M, Wen M-C, Li C-Y, Cheng C-H, Wu M-J, Chen C-H, et al. Impact of recurrent lupus nephritis on lupus kidney transplantation: a 20-year single center experience. Clin Rheumatol. 2012;31(4):705–710
Ghafari A, Etemadi J, Ardalan MR. Renal transplantation in patients with lupus nephritis: a single-center experience. Transplant Proc. 2008;40(1):143–144
Bumgardner G, Mauer S, Payne W, Dunn D, Sutherland D, Fryd D, et al. Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation. 1988;46(5):703–709
Villaverde Verdejo.P Fernández Rivera C.Alonso Hernández A.Garcia Naveiro R.Cao Vilariño M.Tresancos Fernández C , . Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease. Transplant Proc. 2005;37(3):1426–1427
Dong G, Panaro F, Bogetti D, Sammartino C, Rondelli D, Sankary H, et al. Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease. Clin Transplant. 2005;19(1):56–60
Contreras G, Mattiazzi A, Guerra G, Ortega LM, Tozman EC, Li H, et al. Recurrence of lupus nephritis after kidney transplantation. J Am Soc Nephrol. 2010;21(7):1200–1207
Ponticelli C, Moroni G, Glassock RJ. Recurrence of secondary glomerular disease after renal transplantation. Clin J Am Soc Nephrol. 2011;6(5):1214–1221
Tsai J-P, Lian J-D, Wu S-W, Hung T-W, Tsai H-C, Chang H-R. Long-term impact of pretransplant and posttransplant diabetes mellitus on kidney transplant outcomes. World J Surg.
;35(12):2818–2825
Schiel R, Heinrich S, Steiner T, Ott U, Stein G. Long-term prognosis of patients after kidney transplantation: a comparison of those with or without diabetes mellitus. Nephrol Dial Transplant. 2005;20(3):611–617
Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Akao M, Ono K, et al. Impact of diabetes on cardiovascular outcomes in hemodialysis patients undergoing coronary revascularization. Circ J. 2011;75(7):1616–1625
Berthoux F, Mariat C. Cardiovascular death after renal transplantation remains the first cause despite significant quantitative and qualitative changes. Transplantation. 2010;89(7):806
Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant. 2008;8(3):593–599
Rocha A, Malheiro J, Martins LS, Fonseca I, Dias L, Pedroso S, et al. Kidney transplantation in type 2 diabetic patients?:: A matched survival analysis. Transplant Proc. 2013;45(6):2141–2146
Roozbeh J, Razmkon AR, Jalaeian H, Raiss-Jalali GA, Behzadi S, Sagheb MM, et al. Outcome of kidney transplantation in patients with polycystic kidney disease: A single center study. Saudi J Kidney Dis Transpl. 2008;19(1):72–75
Jacquet A, Pallet N, Kessler M, Hourmant M, Garrigue V, Rostaing L, et al. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int. 2011;24(6):582–587
Sulikowski T, Tejchman K, Zietek Z, Rózanski J, Domanski L, Kaminski M, et al. Experience with autosomal dominant polycystic kidney disease in patients before and after renal transplantation: a 7-year observation. Transplant Proc. 2009;41(1):177–180
Niemczyk M, Niemczyk S, Paczek L. Autosomal dominant polycystic kidney disease and transplantation. Ann Transplant. 2009;14(4):86–90
Pirson Y, Christophe J, Goffin E. Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 1996;11(6):24–28
Fitzpatrick P, Torres V, Charboneau J, Offord K, Holley K, Zincke H. Long-term outcome of renal transplantation in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1990;15(6):535–543
Azevedo L, Romão J, Malheiros D, Saldanh a L, Ianhez L, Sabbaga E. Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients. Nephrol Dial Transplant. 1998;13(11):2894–2898
Fuentes L, Hernandez D, Ruiz P, Blanca L, Lopez V, Sola E, et al. Survival of lupus Nephritis Patients After Renal Transplantation In Malaga. Transplant Proc. 2012;44(7):2067–2068
Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls. Arthritis Rheum. 1998;41(8):1438–1445
Nyberg G, Karlberg I, Svalander C, Hedman L, Blohmé I. Renal transplantation in patients with systemic lupus erythematosus: increased risk of early graft loss. Scand J Urol Nephrol. 1990;24(4):307–313
Ward MM. Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis. Kidney Int. 2000;57(5):2136–2143
Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in systemic lupus erythematosus. Semin Arthritis Rheum. 1997;27(1):17–26
Stone JH. End-stage renal disease in lupus: disease activity, dialysis, and the outcome of transplantation. Lupus. 1998;7(9):654–659
Johnston O, O'Kelly P, Donohue J, Walshe JJ, Little DM, Hickey D, et al. Favorable graft survival in renal transplant recipients with polycystic kidney disease. Ren Fail. 2005;27(3):309–314
O'Toole SM, Fan SL, Yaqoob MM, Chowdhury TA. Managing diabetes in dialysis patients. Postgrad Med J. 2012;88(1037):160–166
Cameron JS. Lupus nephritis. J Am Soc Nephrol JASN. 1999;10(2):413–424
Bartosh SM, Fine RN, Sullivan EK. Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American pediatric renal transplant cooperative study. Transplantation. 2001;72(5):973–978
Nyberg G, Blohmé I, Persson H, Olausson M, Svalander C. Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study. Nephrol Dial Transplant. 1992;7(11):1116–1123
Moroni G, Tantardini F, Gallelli B, Quaglini S, Banfi G, Poli F, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005;45(5):903–911
Deegens JKJ, Artz MA, Hoitsma AJ, Wetzels JFM. Outcome of renal transplantation in patients with systemic lupus erythematosus. Transpl Int. 2003;16(6):411–418
Contreras G, Li H, Gonzalez-Suarez M, Isakova T, Scialla JJ, Pedraza F, et al. Kidney allograft survival of African American and Caucasian American recipients with lupus. Lupus. 2014;23(2):151–158
Ward M. Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis. Kidney Int. 2000;57(5):2136–2143
Massy Z, Ma J, Louis T, Kasiske B. Lipid-lowering therapy in patients with renal disease. Kidney Int. 1995;48(1):188–198
Clark W, Jevnikar A. Renal transplantation for end-stage renal disease caused by systemic lupus erythematosus nephritis. Semin Nephrol. 1999;19(1):77–85
Downloads
- Carlos Andres Zapata-Chica, Lina Maria Serna-Higuita, John Fredy Nieto-Ríos, Fabian David Casas-Arroyave, Jorge Hernando Donado-Gómez, Sodium bicarbonate versus isotonic saline solution to prevent contrast-induced nephropathy : a systematic review and meta-analysis , Colombia Medica: Vol. 46 No. 3 (2015)
- Catalina María Vélez Echeverri, Lina María Serna-Higuita, Ana Katherina Serrano Gayubo, Carolina Ochoa-García, Luisa Rojas Rosas, Ana María Bedoya, Margarita Suárez, Catalina Hincapie, Adriana Henao, Diana Ortiz, Juan José Vanegas Ruiz, Jhon Jairo Zuleta, David Andrés Espinal, Resistance profile for pathogens causing urinary tract infection in a pediatric population, and antibiotic treatment response, at a university hospital 2010-2011 , Colombia Medica: Vol. 45 No. 1 (2014)
- John Fredy Nieto-Rios, Sandra Milena Gómez de los Ríos, Lina María Serna-Higuita, Catalina Ocampo-Kohn, Arbey Aristizabal-Alzate, Kenny Mauricio Gálvez-Cárdenas, Gustavo Adolfo Zuluaga-Valencia, Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor. , Colombia Medica: Vol. 47 No. 4 (2016)
Accepted 2016-02-15
Published 2016-02-19
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use